Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02360787 · ClinicalTrials.gov registry record · NA
The Effects of Including Almonds in a Weight Loss Trial
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02360787: Completed NA study, sponsored by Purdue University.
NCT02360787 is a NA study that has completed, run by Purdue University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02360787, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.
Primary Outcome
Changes in body weight, BMI, fat mass, waist circumference and abdominal height over 12 weeks
Interventions
- BEHAVIORAL Energy restriction
- BEHAVIORAL Almonds (15% kcal/day)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-10 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02360787 record still lists
NCT02360787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Energy restriction is the first listed.
NCT02360787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02360787 about?
NCT02360787 is a clinical study titled "The Effects of Including Almonds in a Weight Loss Trial". The purpose of this study is to determine whether inclusion of almonds in a weight loss regimen will augment the rate of weight loss, promote a greater fat mass/fat-free mass ratio of weight loss, improve blood pressure and ameliorate the post-lunch dip in cognitive function.
What is the current status of trial NCT02360787?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2012-10. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02360787?
The interventions under investigation include: Energy restriction (BEHAVIORAL), Almonds (15% kcal/day) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02360787?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02360787's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia